OPKO HEALTH, INC. - Common Stock, par value $0.01 per share (OPK)

CUSIP: 68375N103

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class
Equity / Common Stock, par value $0.01 per share
Total 13F shares
21,664
Total 13F value
$32,496
Holder snapshot 5 signals
Share change
-13,554
SEC-reported price per share
$1.50
Number of holders
4
Value change
-$15,452
Number of sells
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
749,059,842

Security key

68375N103

Report period

Q2 2026

Institutions

4

Top holders

4

OPK full security history Ownership snapshot Full 13F holder table Previous quarter: Q1 2026 OPKO HEALTH, INC. SEC filings OPKO HEALTH, INC. company facts OPKO HEALTH, INC. 13D/G history

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of OPK - OPKO HEALTH, INC. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Et al Phillip Frost MD
Disclosed value leader
Et al Phillip Frost MD
Comparable rows
15/15
Latest evidence
29 Jun 2026
13D/G 3/4/5 13F Lead comparable stake: 34% 13D/G row: Et al Phillip Frost MD Showing 1-6 of 15 holder rows.

Quick read

Et al Phillip Frost MD leads the comparable SEC ownership view at 34%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Et al Phillip Frost MD's linked filing trail.
Comparable ownership Top 5
Et al Phillip Frost MD 34%
Rubric Capital Management LP 6%
Jane Ph D. Hsiao 4.5%
BlackRock, Inc. 4.8%
VANGUARD PORTFOLIO MANAGEMENT LLC 2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Et al Phillip Frost MD
13D/G 3/4/5
FROST PHILLIP MD ET AL · CEO & Chairman, Director, 10%+ Owner
13D/G 3/4/5
34%
$370,372,639
255,429,406 shares
 +$3,690,250 29 Jun 2026
Rubric Capital Management LP
13D/G 13F
Company
13D/G 13F
6%
$63,137,011
47,791,243 shares
 $0 30 Jun 2025
Jane Ph D. Hsiao
13D/G 3/4/5
HSIAO JANE PH D · Vice Chairman & CTO, Director
13D/G 3/4/5
4.5%
$50,304,970
35,677,284 shares
 $0 02 Apr 2025
BlackRock, Inc.
13F
Company
13F
4.8%
$41,304,733
36,232,223 shares
 — 31 Mar 2026
VANGUARD PORTFOLIO MANAGEMENT LLC
13F
Company
13F
2%
$16,837,480
14,769,719 shares
 — 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
1.9%
$16,529,047
14,499,164 shares
 — 31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
4
Shares
21,664
Rows available
4
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
232
Q2 2026 holders
4
Holder diff
-228
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .